Clinical Trial

Testing Experimental Medication in Healthy Subjects

Study Description

A Bioavailability Study of NALDEBAIN ER Injection and Nalbuphine Injection in Healthy Volunteers.

This is an open-label, sequential 2 cohort, intramuscular injection study in healthy volunteers. The study will enroll approximately 24 healthy volunteers to examine the safety, pharmacokinetics, and bioavailability after intramuscular injection of NALDEBAIN ER Injection and nalbuphine injection.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Dinalbuphine sebacate

150 mg Dinalbuphine sebacate

Drug - Nalbuphine HCl

20 mg Nalbuphine

Additional Information

Official Study Title

A Bioavailability Study of NALDEBAIN ER Injection and Nalbuphine Injection in Healthy Volunteers.

Clinical Trial ID

NCT04256434

ParticipAid ID

e0R5Gb